FibroBiologics

Houston, United States · Founded 2021 · $25.9M raised

Headquarters
Houston, Texas
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$25.9M
Last Round
$25.0M Corporate RoundDec 2024
Rounds
4

About

FibroBiologics is a clinical-stage cell therapy company developing fibroblast-based treatments and potential cures for chronic autoimmune and degenerative diseases. Its pipeline targets conditions including multiple sclerosis, degenerative disc disease, osteoporosis, and burns using proprietary fibroblast cell and fibroblast-derived material technologies. The company is publicly traded on Nasdaq (FBLG) and operates a dedicated research and manufacturing laboratory in Houston, Texas.

Summary

FibroBiologics is a Biotech company based in Houston, United States, founded in 2021. It has raised $25.9M in total across 4 rounds, most recently a $25.0M Corporate Round round in Dec 2024.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundDec 2024
$25.0M

Sign up to see all 4 rounds

Grant through Corporate Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

FibroBiologics on Indexed.vc
<a href="https://indexed.vc/companies/fibrobiologics"><img src="https://indexed.vc/api/badge/company/fibrobiologics" alt="FibroBiologics on Indexed.vc" width="260" height="76" /></a>